Generic Injectables Market Report

China Generic Injectables Industry Market Research Report 2023-2029

  • POSTDATE：Oct 06, 2023
  • PAGES：155
  • REPORT CODE：GMM1831666
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Generic Injectables industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Lupin Pharmaceuticals

    • Hikma Pharmaceuticals

    • Mylan

    • Sandoz International

    • Biocon

    • Teva Pharmaceutical

    • Baxter

    • Fresenius

    • Pfizer

    By Type:

    • Small Molecule Injectables

    • Large Molecule Injectables (Biosimilars)

    By Application:

    • Cardiology

    • Oncology

    • Infectious Diseases

    • Immunology

    • Diabetes

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Generic Injectables Market Overview 2018-2029

    • 1.1 China Generic Injectables Industry Development Overview

    • 1.2 China Generic Injectables Industry Development History

    • 1.3 China Generic Injectables Industry Market Size (2018-2029)

    • 1.4 China Generic Injectables Market Analysis by Type from Production Side

      • 1.4.1 China Generic Injectables Production Volume, Production Value and Growth Rate of Small Molecule Injectables (2018-2029)

      • 1.4.2 China Generic Injectables Production Volume, Production Value and Growth Rate of Large Molecule Injectables (Biosimilars) (2018-2029)

    • 1.5 China Generic Injectables Market Analysis by Application from Consumption End

      • 1.5.1 China Generic Injectables Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

      • 1.5.2 China Generic Injectables Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.3 China Generic Injectables Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.4 China Generic Injectables Sales Volume, Sales Value and Growth Rate of Immunology (2018-2029)

      • 1.5.5 China Generic Injectables Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • 1.6 China Generic Injectables Market Analysis by Region

      • 1.6.1 North China Generic Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Generic Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Generic Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Generic Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Generic Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Generic Injectables Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Generic Injectables Market Size and Growth Rate from 2018-2029

    Chapter 2 China Generic Injectables Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Generic Injectables Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Generic Injectables Market Status and Competition Analysis in 2023

      • 2.2.3 China Generic Injectables Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Generic Injectables Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Generic Injectables Industry Development

    Chapter 3 Generic InjectablesIndustry Chain Analysis

    • 3.1 Generic Injectables Industry Chain

    • 3.2 Generic Injectables Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Generic Injectables Market

    • 3.3 Generic Injectables Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Generic Injectables Market

    Chapter 4 China Generic Injectables Market, by Type

    • 4.1 China Generic Injectables Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Generic Injectables Total Production Volume and Growth Rate from Production Side

    • 4.5 China Generic Injectables Production Volume and Growth Rate, by Type

      • 4.5.1 China Generic Injectables Production Volume and Growth Rate of Small Molecule Injectables

      • 4.5.2 China Generic Injectables Production Volume and Growth Rate of Large Molecule Injectables (Biosimilars)

    Chapter 5 China Generic Injectables Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Generic Injectables Total Market Size and Growth Rate from Consumption End

    • 5.5 China Generic Injectables Market Size and Growth Rate, by Application

      • 5.5.1 China Generic Injectables Market Size and Growth Rate of Cardiology

      • 5.5.2 China Generic Injectables Market Size and Growth Rate of Oncology

      • 5.5.3 China Generic Injectables Market Size and Growth Rate of Infectious Diseases

      • 5.5.4 China Generic Injectables Market Size and Growth Rate of Immunology

      • 5.5.5 China Generic Injectables Market Size and Growth Rate of Diabetes

    Chapter 6 China Generic Injectables Market, by Region

    • 6.1 China Generic Injectables Production Volume and Production Value, by Region

    • 6.2 China Generic Injectables Sales Volume and Sales Value, by Region

    Chapter 7 North China Generic Injectables Market Analysis

    • 7.1 North China Generic Injectables Market, by Type

    • 7.2 North China Generic Injectables Market, by Application

    Chapter 8 Central China Generic Injectables Market Analysis

    • 8.1 Central China Generic Injectables Market, by Type

    • 8.2 Central China Generic Injectables Market, by Application

    Chapter 9 South China Generic Injectables Market Analysis

    • 9.1 South China Generic Injectables Market, by Type

    • 9.2 South China Generic Injectables Market, by Application

    Chapter 10 East China Generic Injectables Market Analysis

    • 10.1 East China Generic Injectables Market, by Type

    • 10.2 East China Generic Injectables Market, by Application

    Chapter 11 Northeast China Generic Injectables Market Analysis

    • 11.1 Northeast China Generic Injectables Market, by Type

    • 11.2 Northeast China Generic Injectables Market, by Application

    Chapter 12 Southwest China Generic Injectables Market Analysis

    • 12.1 Southwest China Generic Injectables Market, by Type

    • 12.2 Southwest China Generic Injectables Market, by Application

    Chapter 13 Northwest China Generic Injectables Market Analysis

    • 13.1 Northwest China Generic Injectables Market, by Type

    • 13.2 Northwest China Generic Injectables Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Lupin Pharmaceuticals

        • 14.1.1 Lupin Pharmaceuticals Company Profile

        • 14.1.2 Lupin Pharmaceuticals Generic Injectables Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Hikma Pharmaceuticals

        • 14.2.1 Hikma Pharmaceuticals Company Profile

        • 14.2.2 Hikma Pharmaceuticals Generic Injectables Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Mylan

        • 14.3.1 Mylan Company Profile

        • 14.3.2 Mylan Generic Injectables Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sandoz International

        • 14.4.1 Sandoz International Company Profile

        • 14.4.2 Sandoz International Generic Injectables Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Biocon

        • 14.5.1 Biocon Company Profile

        • 14.5.2 Biocon Generic Injectables Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Teva Pharmaceutical

        • 14.6.1 Teva Pharmaceutical Company Profile

        • 14.6.2 Teva Pharmaceutical Generic Injectables Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Baxter

        • 14.7.1 Baxter Company Profile

        • 14.7.2 Baxter Generic Injectables Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Fresenius

        • 14.8.1 Fresenius Company Profile

        • 14.8.2 Fresenius Generic Injectables Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Pfizer

        • 14.9.1 Pfizer Company Profile

        • 14.9.2 Pfizer Generic Injectables Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Generic Injectables Industry Research Conclusions

    • 15.2 Generic Injectables Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Generic Injectables Industry Market Size (2018-2029)

    • Figure China Generic Injectables Production Volume, Production Value and Growth Rate of Small Molecule Injectables (2018-2029)

    • Figure China Generic Injectables Production Volume, Production Value and Growth Rate of Large Molecule Injectables (Biosimilars) (2018-2029)

    • Figure China Generic Injectables Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

    • Figure China Generic Injectables Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Generic Injectables Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China Generic Injectables Sales Volume, Sales Value and Growth Rate of Immunology (2018-2029)

    • Figure China Generic Injectables Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • Figure North China Generic Injectables Market Size and Growth Rate from 2018-2029

    • Figure Central China Generic Injectables Market Size and Growth Rate from 2018-2029

    • Figure South China Generic Injectables Market Size and Growth Rate from 2018-2029

    • Figure East China Generic Injectables Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Generic Injectables Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Generic Injectables Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Generic Injectables Market Size and Growth Rate from 2018-2029

    • Figure Generic Injectables Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Generic Injectables Market Share by Type in 2018

    • Figure China Generic Injectables Market Share by Type in 2023

    • Figure China Generic Injectables Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Generic Injectables Production Volume and Growth Rate of Small Molecule Injectables (2018-2023)

    • Figure China Generic Injectables Production Volume and Growth Rate of Large Molecule Injectables (Biosimilars) (2018-2023)

    • Figure China Generic Injectables Market Share by Application in 2018

    • Figure China Generic Injectables Market Share by Application in 2023

    • Figure China Generic Injectables Total Market Size and Growth Rate from Consumption End

    • Figure China Generic Injectables Market Size and Growth Rate of Cardiology (2018-2023)

    • Figure China Generic Injectables Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Generic Injectables Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China Generic Injectables Market Size and Growth Rate of Immunology (2018-2023)

    • Figure China Generic Injectables Market Size and Growth Rate of Diabetes (2018-2023)

    • Table China Generic Injectables Production Volume by Region (2018-2023)

    • Table China Generic Injectables Production Volume Share by Region (2018-2023)

    • Figure China Generic Injectables Production Volume Share by Region (2018-2023)

    • Table China Generic Injectables Production Value by Region (2018-2023)

    • Table China Generic Injectables Production Value Share by Region (2018-2023)

    • Figure China Generic Injectables Production Value Share by Region (2018-2023)

    • Table China Generic Injectables Sales Volume by Region (2018-2023)

    • Table China Generic Injectables Sales Volume Share by Region (2018-2023)

    • Figure China Generic Injectables Sales Volume Share by Region (2018-2023)

    • Table China Generic Injectables Sales Value by Region (2018-2023)

    • Table China Generic Injectables Sales Value Share by Region (2018-2023)

    • Figure China Generic Injectables Sales Value Share by Region (2018-2023)

    • Table North China Generic Injectables Production Volume by Type (2018-2023)

    • Table North China Generic Injectables Production Volume Share by Type (2018-2023)

    • Figure North China Generic Injectables Production Volume Share by Type (2018-2023)

    • Table North China Generic Injectables Sales Volume by Application (2018-2023)

    • Table North China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Figure North China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Table Central China Generic Injectables Production Volume by Type (2018-2023)

    • Table Central China Generic Injectables Production Volume Share by Type (2018-2023)

    • Figure Central China Generic Injectables Production Volume Share by Type (2018-2023)

    • Table Central China Generic Injectables Sales Volume by Application (2018-2023)

    • Table Central China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Figure Central China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Table South China Generic Injectables Production Volume by Type (2018-2023)

    • Table South China Generic Injectables Production Volume Share by Type (2018-2023)

    • Figure South China Generic Injectables Production Volume Share by Type (2018-2023)

    • Table South China Generic Injectables Sales Volume by Application (2018-2023)

    • Table South China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Figure South China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Table East China Generic Injectables Production Volume by Type (2018-2023)

    • Table East China Generic Injectables Production Volume Share by Type (2018-2023)

    • Figure East China Generic Injectables Production Volume Share by Type (2018-2023)

    • Table East China Generic Injectables Sales Volume by Application (2018-2023)

    • Table East China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Figure East China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Table Northeast China Generic Injectables Production Volume by Type (2018-2023)

    • Table Northeast China Generic Injectables Production Volume Share by Type (2018-2023)

    • Figure Northeast China Generic Injectables Production Volume Share by Type (2018-2023)

    • Table Northeast China Generic Injectables Sales Volume by Application (2018-2023)

    • Table Northeast China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Table Southwest China Generic Injectables Production Volume by Type (2018-2023)

    • Table Southwest China Generic Injectables Production Volume Share by Type (2018-2023)

    • Figure Southwest China Generic Injectables Production Volume Share by Type (2018-2023)

    • Table Southwest China Generic Injectables Sales Volume by Application (2018-2023)

    • Table Southwest China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Table Northwest China Generic Injectables Production Volume by Type (2018-2023)

    • Table Northwest China Generic Injectables Production Volume Share by Type (2018-2023)

    • Figure Northwest China Generic Injectables Production Volume Share by Type (2018-2023)

    • Table Northwest China Generic Injectables Sales Volume by Application (2018-2023)

    • Table Northwest China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Generic Injectables Sales Volume Share by Application (2018-2023)

    • Table Lupin Pharmaceuticals Company Profile

    • Table Lupin Pharmaceuticals Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Hikma Pharmaceuticals Company Profile

    • Table Hikma Pharmaceuticals Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Sandoz International Company Profile

    • Table Sandoz International Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Fresenius Company Profile

    • Table Fresenius Generic Injectables Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Generic Injectables Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US